| Vol 7 n° 1 - Early stages of schizophrenia |
Alert |
|
To
print this page in good conditions, please select the "Landscape" mode
of your printer.
|
|
ear Colleagues,
Although schizophrenia is a relatively widespread disorder, its forms can differ in
terms of clinical expression, the timing of the diagnosis, the duration of the disease, and
the patient’s environment.
The physician involved in the treatment of this condition may have many questions:
• Are there factors that trigger schizophrenia?
• Are there environmental conditions that reinforce
or modify certain aspects of the
disease?
• Are there premorbid manifestations before the first
episode of schizophrenia?
• Are there early markers that could be used to confirm
the diagnosis of the psychotic
state?
• Is the presence of cognitive disorders a risk factor
or a symptom of the disease?
In all cases, the main problem is to establish the diagnosis of a schizophrenic state
as early as possible, and to know which treatment is best to use in the early stage of the
disease. This is why we decided to address these questions in this issue of Dialogues in
Clinical Neuroscience devoted to the Early stages of schizophrenia.
We would like to thank
Profs Michael Davidson and Carol Tamminga for their
work in coordinating this
issue with articles written by the most prestigious leaders in
the field.
Yours sincerely,
Jean-Paul Macher, MD
Marc-Antoine Crocq, MD
